Panelists on stage at the Global HPV Consortium

The Global HPV Consortium

A public-private movement to prevent Human Papilloma Virus (HPV) infection and eliminate cervical cancer as a public health concern.

An increased sense of urgency is needed as the world falls behind

Since introduction in 2006, HPV vaccines have proven safe and effective in protecting against infection and preventing cervical cancer. Yet, the burden of HPV diseases continues to rise with an estimated 600,000 new cases of cervical cancer and over 340,000 deaths each year.

To respond to these life-threatening trends, the Sabin Vaccine Institute, as consortium secretariat, along with a diverse, and expanding, set of partners will mobilize action across three pillars:

The Global HPV Consortium will be guided by global goals, including WHO’s Immunization Agenda 2030 and Cervical Cancer Elimination Initiative:

Who We Are

HPV Action Plan Mockup File

Global HPV Action Plan

The Consortium’s Action Plan seeks to respond to the needs and challenges that countries and communities face to make cervical cancer history. The action plan will encompass four key areas:

  • Advocacy and Thought Leadership
  • Knowledge Management and Exchange
  • Convening of Key Stakeholders
  • Country-Based Support